AND KEYWORDS Aims: Echocardiography has become an indispensable tool for the study of heart performance, improving the monitoring of individuals with cardiac diseases. Diverse genetic factors associated with echocardiographic measures of heart structure and functions have been previously reported. The impact of several apoptotic genes in heart development identified in experimental models prompted us to assess their potential association with indicators of human cardiac function. This study started with the aim to investigate the possible association of variants of apoptotic genes with echocardiographic traits and to identify new genetic markers associated with cardiac function. Methods and results: Genome wide data from different studies were obtained from public repositories. After quality control and imputation, association analyses confirm the role of caspases and other apoptosis related genes with cardiac phenotypes. Moreover, enrichment analysis showed an over-representation of genes, including some apoptotic regulators, associated with Alzheimer's disease (AD). We further explored this unexpected observation which was confirmed by genetic correlation analyses. Conclusions: Our findings show the association of apoptotic gene variants with echocardiographic indicators of heart function and reveal a novel potential genetic link between echocardiographic measures in healthy populations and cognitive decline later on in life. These findings may have important implications for preventative strategies combating Alzheimer's disease.
INTRODUCTION
Echocardiographic assessment of cardiac structure offers prognostic information about cardiac conditions such as heart failure (HF). 1 Pathological processes including cardiomyocyte cell death, inflammatory cell response and changes in interstitial tissue of the heart are factors leading to adverse remodelling and HF. 2 A number of apoptotic genes have been investigated as potential targets to prevent cardiomyocyte death, but it is now increasingly evident that caspase-dependent cell death plays a minor if any role in adult myocyte loss, 3 which involves Cyclophilin D 4 and calpains. 5 By contrast, caspase proteins are now recognized as important factors for initial differentiation of stem cells to cardiomyocytes 6 and its deficiency in vivo was shown to induce abnormal heart development. 7, 8 In rodent cardiomyocytes, caspase-3 is involved in WNT signalling and myocyte growth 9, 10 and also contributes to muscle-specific gene splicing by cleaving PTB. 11 In addition, apoptotic DNA nucleases were shown to play a role in the developmental process of C.elegans including the C.elegans Caspase-associated DNase (CAD), ENDOG and TATD orthologs. 12 Furthermore, ENDOG also contributes to the signalling pathways determining myocyte size 13 through the control of reactive oxygen radicals (ROS). 14 These facts lead us to hypothesize that caspases and the nucleases ENDOG and TATD play relevant functions in cardiomyocyte proliferation and maturation during development.
Genome wide association studies have been performed for evaluating comprehensive sets of echocardiographic traits in well characterized individuals included in large cohort studies. 15, 16 Using data from publicly available repositories, we aimed to explore the association between a selected group of candidate apoptosis-related genes and these echocardiographic phenotypes by means of meta-GWAS. Furthermore, we aimed to assess previously reported signals in our study datasets and performed an agnostic analysis to investigate relevant pathways revealed for each trait. Following the leading results of this analysis, we further explored the unsuspected genetic relationship between Alzheimer's Disease (AD) and these echocardiographic traits, by estimating their genetic correlation, and identifying common genetic determinants of these conditions.
METHODS

STUDY COHORTS
Heart study cohorts
The four cardiovascular datasets analysed in this study were downloaded from dbGAP (https://www.ncbi.nlm.nih.gov/gap) after requesting the appropriate permissions. In the case of a multi-ethnic study, only Caucasian samples after principal component analysis (PCA) were retained for analysis. A summary of the clinical characteristics of these populations is shown in Table 1 . A full description of each of them is provided as a Supplementary Note.
Alzheimer's disease study cohorts
A total of seven AD datasets were used to further explore the observed enrichment of top genes derived from the analysis of echocardiographic traits on genes involved in AD pathways. As for previously described datasets, only Caucasian samples after principal component analysis (PCA) were retained for analysis. Demographic characteristics of these datasets are summarized in the Supplementary Table 1 whereas a full description is provided as a Supplemental Note.
PHENOTYPES
Echocardiographic Phenotypes
Data from the most recent available echocardiographic examinations of each cohort were included in this study. The following five phenotypes were analysed: Left Ventricular Mass (LVM) (g), End-Diastolic Diameter of the Aortic Root (AROT) (cm), End-Diastolic LV Internal Dimension (LVID) (cm), Left Atrial Size (LAS) (cm), and LV Wall Thickness (LVWT)(cm). The latter was defined as the sum of the End-Diastolic Thicknesses of the Posterior Wall (TPW) and End-Diastolic Thicknesses of the Interventricular Septum (TIS).
LVM was calculated using the formula 0.8 [1.04{(LVID + TIS + TPW) 3 −(LVID) 3 }] + 0.6. 17
GENOTYPING AND IMPUTATION
The cardiovascular datasets included in this study were genotyped using different platforms:
CARDIA and MESA were genotyped using the Affymetrix Genome-Wide Human 6.0 array, whereas the FHS was genotyped using the Affymetrix Human 500k array and the CHS cohort with the Illumina HumanCNV370-Duo v1.0. AD datasets were genotyped using the Illumina arrays Human 610-Quad BeadChip (ADNI1, AddNeuroMed batch 1), the HumanOmniExpress BeadChip (ADNI2/GO, AddNeuroMed batch 2, ADGC dataset 3), the Human660W-Quad (ADGC datasets 1&2) and the HumanHap300-Duo BeadChip (The Mayo study) or the Affymetrix 250k NspI (the Neocodex-Murcia study), 500k (the TGEN and GenADA studies) or 6.0 (ROSMAP study) arrays.
Prior to imputation, we first performed an extensive quality control excluding individuals with more than 3% missing genotypes, with excess autosomal heterozygosity (>0.35), those showing a discrepancy between genotypic and reported sex, as well as individuals of non-European ancestry based on PCA analyses using SMARTPCA. 18 At the genotype level, we removed SNPs with missing genotype rate > 5%, not in Hardy-Weinberg equilibrium (p<10 -6 in controls) and
SNPs with minor allele frequency (MAF) < 1%. Duplicated and related individuals were identified and removed by means of IBS estimates within and across studies.
Genotype imputation was performed using the minimac3 algorithm and the SHAPEIT tool for haplotype phasing at the University of Michigan server using the HRC reference panel (Das et al. 2016). After imputation, SNPs with an R2 quality estimate lower than 0.3 were excluded from further analyses.
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STATISTICAL ANALYSIS
All analyses were performed in Caucasian populations only. Individuals with prevalent myocardial infarction (MI) or congestive heart failure (CHF) were excluded from the study.
Linear regression models available from PLINK software 19 were fitted to investigate the association between genotypes and quantitative phenotypes, with age, sex, body mass index and the four principal components as covariates. For each phenotype, we obtained summary estimates of association across studies by using a fixed-effects model meta-analysis procedure implemented also in PLINK. For the genome wide SNP analysis, the conventional GWAS significance threshold was used (p=5 x 10 -8 ). 20 Gene-wise statistics were computed using MAGMA software, which takes into account physical distance and linkage disequilibrium (LD) between markers. 21 Only SNPs with MAF above 1% were used in these analyses. At each trait, genes were ranked according to the global p mean value. For the candidate gene analysis, considering the number of traits (n=5) and genes (n=20) being explored, we set the threshold for study-wide statistical significance in 5 x 10 -4 .
The top 200 genes from each association analysis were further explored for enrichment in known pathways using the R packages Webgestalt and enrichR 22, 23 with default parameters. The threshold for statistical significance in these analyses was FDR values below 0.1.
In order to explore genetic correlation between different traits we used a bivariate GREML analysis with GTCA software 24 with default parameters. Furthermore, we obtained summary estimates of association across phenotypes performing unweighted meta-analysis of Fisher pvalues. The threshold for statistical significance in all these analyses was p-values below 0.05.
RESULTS
Overall, our study included data from 11,559 individuals with echocardiographic phenotypes from four different datasets (Table 1) . After imputation and quality control, we obtained about 7 million SNPs with MAF>0.01 that were tested for association with echocardiographic traits at each study. We then performed a meta-GWAS to obtain summary estimates of association for each SNP. Genomic inflation factor (λ) ranged from 0.994 to 1.022 in these analyses, indicating absence of population stratification due to hidden population structure ( Figure 1 ). MAGMA software was used for summarising the meta-GWAS SNP results in order to obtain a gene-wise statistic of the association between 18,480 genes and the five phenotypes.
Association of apoptosis-related genes with cardiac phenotypes
Because there is experimental evidence supporting the role of some apoptosis-related genes with cardiac development and disease, we first analysed the potential association of polymorphisms in a series of apoptosis-related genes with the cardiac phenotypes. Table 2 shows the association results of the 20 apoptosis-related candidate genes. Study-wide statistically significant results were observed for the association of a genetic locus on 2q33.1 involving two initiator caspases (CASP8 and CASP10) and the apoptosis regulator protein CFLAR (CASP8 And FADD Like Apoptosis Regulator, c-FLIP) with LVM. The same three genes were also linked to LVID with suggestive results (p<0.05), along with the Fas receptor-associated adaptor FADD (Fasassociated protein with death domain) and BCL2 (B-cell lymphoma-2). BCL2, FADD and TATDN1 (TatD DNase domain containing-1) showed suggestive signals of association with AROT. We did not find evidence of association of any calpain family member with any of the analysed traits (data not shown).
Agnostic GWAS of genetic variants associated with cardiac phenotypes and enrichment analysis of top genes on echocardiographic traits
Although we did not find any GWAS significant signal at SNP-level (p<5x10 -8 ) related with the analysed phenotypes, we observed several suggestive signals at the p<10 -5 level (Supplementary tables 2-6), most of them intragenic ( Figure 1 ). For each genotype, we ranked genes according to the MAGMA computed SNP-wise p-value (Table 3 and Supplementary tables 7-11).
Top 200 ranked genes were tested for enrichment using Webgestalt and EnrichR R packages (Supplementary tables 12-16). These top genes show little overlap across phenotypes ( Figure  2a ), which is reflected in the little overlap of the top ten enriched gene ontology (GO) categories ( Figure 2b ). For both AROT and LVID, we found enrichment on members from the keratin II gene cluster. LVID and LVWT share genes from the olfactory receptor families 52 and 56, whereas LVM and LVWT show enrichment on genes from the haemoglobin locus. Specific signals for LVID arise from genes involved in long QT signals and atrial fibrillation, the HLA locus and the vesicular and lysosomal system for LAS and grow factors such as VEGF and FGF were observed for LVWT. Surprisingly, in pathway analysis, we observed an enrichment in Alzheimer related pathways for both LVID and LVM, involving the PSEN2, MPO, SMAD1, ADRB2, APH1B, MAPK9 and RBP genes.
Genetic correlation analysis between echocardiographic traits and AD
The association of gene variants related to echocardiographic measures with mental illnesses prompted us to explore in more depth the relationship between the echocardiographic phenotypes and AD. We performed a genetic correlation analysis using the study dataset (comprised by 11,559 individuals with echocardiographic phenotypes) along with 12,730 AD cases and controls both from internal and publicly available databases. First, we estimated the proportion of variance, as a proxy of trait heritability, explained by all SNPs in each one of these traits, 25 which was higher for Alzheimer disease (0.38) than for the echocardiographic phenotypes (range: 0.17-0.36). Then, we looked for shared genetic loci between echocardiographic traits and AD using GREML analyses confirming the involvement of AD genes in heart performance detected during enrichment analyses. Specifically, we observed a positive correlation between AD and LAS (rG=0.167, p=0.0334), and negative correlations between AD and LVID (rG=-0.196, p=0.0056), and AD and LVM (rG=-0.198, p=0.0165); of note, LVM and LVID are the most correlated echocardiographic traits (rG=0.988, p<0.00001).
The sign of the rG estimates determines whether a direct or inverse relationship between the two phenotype traits is observed. Therefore, our results suggest that SNPs that increase the risk of AD tend to be associated with increasing LAS values. On the contrary, we found that SNPs associated with increased risk of AD tend to be associated with decreasing ventricular measures (or vice versa), in particular LVID and LVM.
Based on these findings we performed a SNP-wise meta-analysis by pooling Fisher association p-values of two or more phenotypes. Thus, we combined in these meta-analyses p-values for LAS&AD, LVID&AD, LVM&AD, LAS&LVID&LVM&AD and LVID&LVM&AD and calculated gene-wise statistics (Supplementary tables [17] [18] [19] [20] [21] . We performed a new enrichment analysis for identifying relevant functions and pathways determined by the top genes shared by AD and cardiac measures (Supplementary tables [22] [23] [24] [25] . The comparison of the enrichment results using Venn diagrams ( Figure 3 ) showed that apoptosis related pathways driven by the CASP8, CASP10 and CFLAR locus, and phospholipid scramblase genes are common elements for LAS, LVID, LVM and AD. We also observed an enrichment on genes present at the neuronal synapse such as glutamate and GABA receptors (GRIN2C, GABRR1, GABRR2 and GABBR2), teneurin (TENM2), calsyntenin (CLSTN3), adenylate cyclase (ADCY4), SLC5A7, LIN7A or LRFN2. The haemoglobin complex, previously found among shared genes by LVID and LVM also seems to be relevant for AD.
DISCUSSION
Our study, based on data from 11,559 individuals free of cardiovascular disease, shows that variants affecting diverse genes involved in apoptosis regulation associate with echocardiographic phenotypes in humans. We have obtained these results by both hypothesisdriven and agnostic approaches. In addition, novel findings from the analysis of our GWAS also include previously unnoticed associations of variants in genes involved in cell proliferation, DNA replication and mRNA splicing with left ventricular morphology. Our data also suggest the existence of a set of genes, mainly related to apoptosis/inflammation signalling, whose variants are associated with both cardiac phenotype and Alzheimer's disease.
Our hypothesis-driven analysis showed that caspases 8 and 10 and the regulatory CFLAR (cFLIP) gene are strong predictors of LVM. Furthermore, our hypothesis-free approach found that caspase dependent pathways were overrepresented among the top 200 genes involved in the LVM phenotype. These results support our a priori hypothesis that the apoptotic signalling influences heart morphology with potential impact on heart performance. Our hypothesis was based in previous experimental work, including our own, showing that deficiency 8, 10 or overexpression 26 of key apoptotic genes altered normal cardiomyocyte differentiation and heart development independently of cell death. Indeed, although these genes are best known for their role in regulating apoptotic cell death, experimental evidences show that the same genes also regulate myocyte proliferation, inflammation and hypertrophy in the heart. 8, 10, [27] [28] [29] Because cell death is not a major event during heart development, and based on the above experimental work, we suggest that the relationship between the apoptotic genes and the cardiac phenotype might involve non-apoptotic functions.
In order to estimate the robustness of our GWAS analysis, we asked whether we had reproduced some signals already observed in previous genetic studies. Indeed, we found the already published link between SMG6, TSR1 and SRR genes and AROT, 15, 16 but failed to detect statistically significant associations of other gene variants, possibly due to the limited power of this study. However, our analysis demonstrated genetic association between variants of genes previously shown to influence heart function and cardiac hypertrophy in experimental models, such as MLF1, 30 which associates with LVM phenotype in our study, and KCNIP2 (KChIP2) 31- The GWAS analysis also showed strong association of variants of a group of 4 genes located in the 11p15.4 chromosomic region coding for odorant receptors with LVWT and LVID.
Expression of these genes in non-neural tissues is related to the control of different processes, including glucose and oxygen homeostasis or cell cycle control, 37 and has been shown to be involved in the regulation of cardiac function in rodent experimental models through interaction with fatty acids. 38 Therefore, our genetic results open the possibility that odorant receptors' activity can influence cardiac function in humans. Interestingly, low OR expression has been found in the cortex of neuro-psychiatric patients 39 and a genetic microduplication in the 11p15.4 region has been associated with familial intellectual disability and autism. 40 For the LVM phenotype, 8 of the 10 top ranked genes are involved in mRNA splicing, DNA replication and cell proliferation, and two are related to protein elongation and folding.
Interestingly, 6 of the top genes associated with ventricular phenotypes have been also associated with mental illnesses including AD, Schizophrenia and bipolar disorder 41, 42 and the 11p15.4 region containing 4 of the 10 top genes for LVWT has been previously associated with intellectual disability. 40 Unexpectedly, we found enrichment on AD related pathways for LAS, LVID and LVM that led us to explore comprehensively a possible link between AD and all these echocardiographic traits. Intriguingly, our results revealed for the first time a potential genetic link between AD and LAS, paired with a negative correlation between AD and either LVM or LVID.
Interestingly, in line with our observation, a recent report found that LAS was independently associated to cognitive function in older adults. 43 The opposite direction of the correlation coefficients for atrial and ventricular measures could be related to the different development patterns of these chambers during embryogenesis 44 and with the described strong association of left atrial size with long-term exposure to vascular risk factors, particularly high blood pressure and obesity. In fact, the CARDIA Brain MRI Substudy found association of higher left atrial volume in early adulthood with impairment of white matter integrity in midlife, but not for ventricular measures. 45 The link between AD and cardiac conditions is not well understood. The old concept of cardiogenic dementia was based on the high incidence of cardiac dysrhythmias observed in patients with dementia due to vascular causes. 46 However, the relation between coronary heart disease (CHD) or HF and AD in epidemiological studies remains controversial, with some studies showing an association with cognitive impairment and dementia [47] [48] [49] whereas others found no association. 50, 51 The fact that both conditions are competing risks complicates the study of their relationship. Lower cardiac index levels are related to lower cerebral blood flow in older adults free of CVD, 52 but individuals with cardiac conditions that did not result in premature death might include many individuals chronically exposed to brain hypoperfusion due to reduced cardiac output that adaptively decreased cerebrovascular resistance through arteriolar dilatation. This kind of antagonistic pleiotropy between these phenotypes has been previously suggested by Beeri et al. after observing that better cognitive performance was associated with worse cardiac functioning in very elderly subjects. 53 Moreover, whereas enlarged ventricular volume (LV hypertrophy) is a marker of diastolic dysfunction, LVM is also a marker of cardiovascular health, positively correlated with physical activity and cardiorespiratory fitness. 54, 55 Population based studies have shown an inverted Ushaped association for LVM values and age, since they rise in adolescence and decline with increased age. 56, 57 Furthermore, a U-shaped association between left ventricular ejection fraction (LVEF), a marker of systolic dysfunction, and abnormal cognitive decline has been reported, with increased dementia risk at the lowest and highest LVEF quintiles. 58 To our knowledge, this is the first report analysing shared genetic factors between echocardiographic measures and AD. This method for estimating genome-wide pleiotropy has the advantage of being free of potential confounders determined by shared epidemiological risk factors such as high blood pressure or atherosclerosis. Our results show a negative genetic correlation for the ventricular measures LVID and LVM and AD, pointing to antagonist pleiotropic effects of shared genes by AD and LV cardiac measures, the main known functions of which are related to apoptosis, oxygen and phospholipid transport and neurotransmission.
While low haemoglobin concentrations are associated with adverse cardiovascular outcomes and poor exercise capacity, increased concentration of the heme group have been found in the pathological lesions of AD patients. 59, 60 Hypoxia is a well known trigger factor for caspase related apoptosis, but caspases have been shown to play a role in cardiomyocyte morphogenesis rather than in cardiomyocyte death, whereas neuronal death is a hallmark of AD. 61 Neurotransmission affects both cardiac and neuronal performance, and a few studies have examined synapse and neuron loss in AD brains and suggested that synaptic changes precede neuron loss. 62, 63 Finally, scramblase proteins, associated with LAS, LVID, LVM and AD in this study, have been involved not only in lipid transport, but also in mitochondrial membrane maintenance promoting cardiolipin synthesis, a key protein for myocardial energetics, and in caspase induced apoptosis. 64 Anyway, lipid metabolism, especially cholesterol and fatty acid biogenesis have been associated with cardiovascular and cognitive phenotypes in adults being a potential common pathway explaining the connection between both groups of disorders and the decline of the incidence of dementia in younger cohorts with a better control of cardiovascular risk factors. 65 In summary, our GWAS data suggest the influence of gene variants affecting the apoptotic/inflammation signalling pathway on left ventricular morphology and cardiac function, uncover novel candidate gene variants regulating echocardiographic phenotypes and establish a genetic link between cardiac morphology alterations, mental illness and Alzheimer's disease The MESA study was supported by contracts HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 and N01-HC-95169 from the National Heart, Lung, and Blood Institute, and by grants UL1-TR-000040, UL1-TR-001079, and UL1-TR-001420 from NCATS. The authors thank the other investigators, the staff, and the participants of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org. This dataset was obtained from the NIH dbGaP repository (phs000209.v6.p2).
The Neocodex-Murcia study was funded by the Fundación Alzheimur (Murcia), the Ministerio 
